Not applicableAvailableNCT04745637
What this trial is testing
Managed Access Programs for INC424, Ruxolitinib
Who this might be right for
Primary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Thrombocythemia Myelofibrosis (PET-MF)+4 more
Novartis Pharmaceuticals